Upload Avatar (500 x 500)
Yanqing Wang
wangyanqing@shmu.edu.cn
Chinese, English
Shanghai
Fudan University
Basic Medical Sciences
  • 1987.9-1992.7 Bachelor's in Pharmacology: Shanghai Medical University
  • 1992.9-1995.7 Master's in Integrated Chinese and Western Medicine: Shanghai Medical University
  • 1996.9-2000.1 Doctorate in Integrated Chinese and Western Medicine: Fudan University
  • 1995.7-2000.9 - Fudan University Shanghai Medical College - Assistant, Lecturer
  • 2000.9-2002.9 - Chiba Cancer Center Research Institute, Japan - Postdoctoral Researcher
  • 2002.9-Present - Fudan University Basic Medical College - Lecturer, Associate Professor, Professor (since 2009.5)
  • 2010.5-Present - Fudan University Institute of Brain Science - Principal Investigator
  • 2013.9-2020.5 - Fudan University Shanghai Medical College - Director of Integrated Chinese and Western Medicine Department
  • 2015.9-Present - Fudan University Institute of Integrated Chinese and Western Medicine - Director of Acupuncture Research Institute
  • 1999: Second Prize for Scientific and Technological Progress by the Ministry of Education
  • 1999: Second Prize for Scientific and Technological Progress by Shanghai Municipality
  • 2001: Second Prize for Scientific and Technological Progress by Shanghai Municipality
  • 2001: Third Prize for Medical Science and Technology by Chinese Medical Association
  • 2004: Fudan University March 8th Red Flag Bearer
  • 2011: Third Prize for Scientific and Technological Progress by Chinese Acupuncture Society
  • 2016: Second Prize for Scientific and Technological Progress by Chinese Society of Integrated Chinese and Western Medicine
  • 2020: Excellent Teacher Encouragement Award by One Health Foundation
Neuroimmunological mechanisms of acupuncture in treating chronic pain and inflammation
Neurobiological mechanisms of cancer pain
  • Glial IL-33 signaling through an ST2-to-CXCL12 pathway in the spinal cord contributes to morphine-induced hyperalgesia and tolerance, Hu XM, Yang W, Zhang MT, Du LX, Tian JH, Zhu JY, Chen Y, Hai F, Liu SB, Mao-Ying QL, Chu YX, Wang YQ*, Mi WL*, 2021
  • Acupuncture for pain management: Molecular mechanism of action, Chen T, WW Zhang, Chu YX*, Wang YQ*, 2020
  • Vascular Endothelial Growth Factor A Signaling Promotes Spinal Central Sensitization and Pain-related Behaviors in Female Rats with Bone Cancer, Hu XM, Yang W, Du LX, Cui WQ, Mi WL, Mao-Ying QL, Chu YX, Wang YQ*, 2019
  • Spinal Serotonin 1A Receptor Contributes to the Analgesia of Acupoint Catgut Embedding by Inhibiting Phosphorylation of the N-Methyl-d-Aspartate Receptor GluN1 Subunit in Complete Freund's Adjuvant-Induced Inflammatory Pain in Rats, Cui WQ, Sun WS, Xu F, Hu XM, Yang W, Zhou Y, Du LX, Zhang WW, Mao-Ying QL, Mi WL, Chu YX, Wang YQ*, 2019
  • Hippocampal PKR/NLRP1 Inflammasome Pathway Is Required for the Depression-Like Behaviors in Rats with Neuropathic Pain, Li Q, Liu S, Zhu X, Mi W, Maoying Q, Wang J, Yu J, Wang Y*, 2019
  • Timing Mechanisms Underlying Gate Control by Feedforward Inhibition, Zhang Y, Liu S, Zhang YQ, Goulding M, Wang YQ*, Ma Q*, 2018
  • Peripheral Leptin Signaling Mediates Formalin-Induced Nociception, Hu ZJ, Han W, Cao CQ, Mao-Ying QL, Mi WL, Wang YQ*, 2018
  • Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling, Liu S, Li Q, Zhang MT, Mao-Ying QL, Hu LY, Wu GC, Mi WL, Wang YQ*, 2016
  • Spinal IL-33/ST2 Signaling Contributes to Neuropathic Pain via Neuronal CaMKII-CREB and Astroglial JAK2-STAT3 Cascades in Mice, Liu S, Mi WL, Li Q, Zhang MT, Han P, Hu S, Mao-Ying QL, Wang YQ*, 2015
  • Early single Aspirin-triggered Lipoxin blocked morphine anti-nociception tolerance through inhibiting NALP1 inflammasome: Involvement of PI3k/Akt signaling pathway, Tian Y, Liu M, Mao-Ying QL, Liu H, Wang ZF, Zhang MT, Wang J, Li Q, Liu SB, Mi WL, Ma HJ, Wu GC, Wang YQ*, 2015
Acupuncture Chronic Pain Inflammation Neuroimmunology Cancer Pain Neurobiology Mechanisms Treatment Research Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.